Clinical Trials Browser

Completed × OTHER × trastuzumab biosimilar HLX02 × Clear all

NCT02152943 2020-12-19

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Phase 1 Completed

Breast Neoplasms